Company News
Location:HOME >Company News
-
On Sept. 28, 2024, first nationwide shipment of Neratinib Maleate Tablets initiated.
- In August 2024, 2Y-Biopharma was honored with the "Excellent Partner" award by Xgene Pharmaceutical.
- July 22nd, 2023, The 2nd International MAH Cooperation innovation Summit Forum
- July 12-13, 2023 The 4th Global Conference & Exhibition on Biopharma Frontier Technology, #T53b
- In Dec. 2022, 2Y-Chem joined Haoyuan Chemexpress and became a wholly-owned subsidiary
- In October 2022, 2Y-Biopharma successfully passed EU QP remote GMP audit
- In September 2022, the innovative drug of the first MAH customer supported by 2Y-Biopharma was appro
- On March 19, 2022, 2Y-Biopharma completed and put into use a new production facility to support late
- In March 2021, 2Y-Biopharma successfully passed the joint State and Provincial NMPA on-site PAI and
- Formulation GMP facility was established in 2017--2Y-Biopharma
- In January 2019, 2Y-Biopharma, Ltd. obtained the drug production license issued by Jiangsu Provincia
